This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Global Collagen And HA-Based Biomaterials Industry

7. CORPORATE ACTIVITY IN THE RECENT PAST - A PERSPECTIVE BUILDER II-39Getinge AB Merges with Datascope Corp II-39Human Biosciences GmbH Sets Up New Facility in Luckenwalde, Germany II-39TiGenix Takes Over Orthomimetics II-39Integra LifeSciences Inks Licensing Deal with Organogenesis II-39Abbott Takes Over Advanced Medical Optics II-40Anika Signs Exclusive Distribution Agreement with CoaptSystems II-40Rousselot Takes Over PEPTAN II-41Alynx Takes Over MiMedx II-41Covidien Acquires Tissue Science Laboratories II-41Warburg Pincus Takes Over Lifecore Biomedical II-41

8. FOCUS ON SELECT KEY PLAYERS II-42 ABBOTT (US) II-42Alcon Laboratories, Inc. (US) II-42Allergan, Inc. (US) II-43Anika Therapeutics, Inc. (US) II-43Bausch & Lomb, Inc. (US) II-44Lifecore Biomedical, LLC (US) II-44Q-Med AB ( Sweden) II-45Sanofi SA ( France) II-45Genzyme (US) II-46Seikagaku Corp. ( Japan) II-46Teijin Pharma Limited ( Japan) II-47

9. GLOBAL MARKET PERSPECTIVE II-48Table 4: World Recent Past, Current & Future Analysis forCollagen and HA-Based Biomaterials by Geographic Region - US, Canada, Japan, Europe and Rest of World Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2010 through 2018 (includes corresponding Graph/Chart) II-48

Table 5: World Historic Review for Collagen and HA-BasedBiomaterials by Geographic Region - US, Canada, Japan, Europe,and Rest of World Markets Independently Analyzed with AnnualSales Figures in US$ Million for Years 2004 through 2009(includes corresponding Graph/Chart) II-49

Table 6: World 15-Year Perspective for Collagen and HA-BasedBiomaterials by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe and Rest of WorldMarkets for Years 2004, 2012 & 2018 (includes correspondingGraph/Chart) II-50Collagen and HA-Based Biomaterials Market by Product Group/Segment II-51Collagen-based Biomaterials Market by Region II-51Table 7: World Recent Past, Current & Future Analysis forCollagen Based Biomaterials by Geographic Region - US, Canada, Japan, Europe, and Rest of World MarketsIndependently Analyzed with Annual Sales Figures in US$Million for Years 2010 through 2018 (includes correspondingGraph/Chart) II-51

Table 8: World Historic Review for Collagen BasedBiomaterials by Geographic Region - US, Canada, Japan, Europe, and Rest of World Markets Independently Analyzedwith Annual Sales Figures in US$ Million for Years 2004through 2009 (includes corresponding Graph/Chart) II-52

Table 9: World 15-Year Perspective for Collagen BasedBiomaterials by Geographic Region - Percentage Breakdown ofDollar Sales for US, Canada, Japan, Europe, and Rest ofWorld Markets for Years 2004, 2012 & 2018 (includescorresponding Graph/Chart) II-53Collagen Based Biomaterials Market by Product Segment II-54Table 10: World Recent Past, Current & Future Analysis forCollagen-based Biomaterials by Product Segment - UrinaryIncontinence Products, Corneal Shields, Facial AestheticDermal Fillers, and Wound Dressings Markets IndependentlyAnalyzed with Annual Sales Figures in US$ Million for Years2010 through 2018 (includes corresponding Graph/Chart) II-54

Table 11: World Historic Review for Collagen-basedBiomaterials by Product Segment - Urinary IncontinenceProducts, Corneal Shields, Facial Aesthetic Dermal Fillers,and Wound Dressings Markets Independently Analyzed withAnnual Sales Figures in US$ Million for Years 2004 through2009 (includes corresponding Graph/Chart) II-55

3 of 12

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
SYM TRADE IT LAST %CHG

Markets

DOW 17,730.11 -27.80 -0.16%
S&P 500 2,076.78 -0.64 -0.03%
NASDAQ 5,009.2140 -3.9090 -0.08%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs